REVB — Revelation Biosciences Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:57 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Revelation Biosciences Selects Avance Clinical As Cro For Phase 2/3 Titan Study
Revelation Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Revelation Biosciences Inc Q2 EPS USD -0.87
Revelation Biosciences Inc expected to post a loss of 83 cents a share - Earnings Preview
Revelation Biosciences Q1 net loss widens as expenses rise
Brief: Revelation Biosciences Inc Q1 EPS USD -2.71
Revelation Biosciences Q4 net loss widens
NASDAQ RESUMED AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 07:50 PM
Revelation Biosciences Q3 net loss narrows to $1.9 mln
Brief: Revelation Biosciences Inc. Q3 EPS USD -1.77
Revelation Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Revelation Biosciences Inc expected to post a loss of $4.45 a share - Earnings Preview